Loading
Universities often refuse to be the legal sponsor of a first-in-human trial because they cannot afford the insurance and liability. A shared public insurance pool would remove that block.
A government- or funder-backed indemnity and insurance pool that covers no-fault compensation and sponsor liability for academic and non-profit sponsored early-phase oncology trials meeting defined quality standards (independent scientific review, GMP product, approved protocol), priced at cost and open to any accredited institution. Sponsor liability and insurance premiums are a frequently cited reason academic legal offices decline to sponsor first-in-human trials of academic products, especially cell and gene therapies, pushing teams to license early on poor terms or to abandon assets. Several countries operate national no-fault schemes for trial injury; extending them to cover sponsor indemnity for academic early-phase trials is a small, cheap change with a large unblocking effect.
Shares Translational research: crossing the valley of death, The valley of death between lab and product.
Shares A national non-profit contract research organisation for academic oncology trials, A global first-in-human network for academic cancer trials with single ethics review, Hospital-exemption cell therapies at scale, backed by a shared registry, The valley of death between lab and product.
Shares Translational research: crossing the valley of death, The valley of death between lab and product.
Shares Translational research: crossing the valley of death, The valley of death between lab and product.
Shares Translational research: crossing the valley of death, The valley of death between lab and product.
Shares A national non-profit contract research organisation for academic oncology trials, The valley of death between lab and product.
Shares Translational research: crossing the valley of death, The valley of death between lab and product.
Shares Translational research: crossing the valley of death, The valley of death between lab and product.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/